[13] Hirose N., Homma S., Arai Y., Kawamura M., Hasegawa H., Ishida H., Shimizu K., Osono Y., Homma A., Nakamura Y., Tokyo Cente- narian Study. 4. Apolipoprotein E phenotype in Japanese centenarians living in the Tokyo Metropolitan area, Nippon Ronen Igakkai Zasshi. 34 (1997) 267–272.

[4] Iachine I.A., Holm N.V., Harris J.R., Begun A.Z., Iachina M.K., Laitinen M., Kaprio J., Yashin A.I., How heritable is individual suscepti- bility to death? The results of an analysis of survival data on Danish,

[5] Spielman R.S., McGinnis R.E., Ewens W.J., Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM), Am. J. Hum. Genet. 52 (1993) 506–516.

[14] Agerholm-Larsen B., Nordestgaard B.G., Steffensen R., Sorensen T.I., Jensen G., Tybjaerg-Hansen A., ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case- referent and retrospective cohort study based on the Copenhagen City Heart Study, Circulation 95 (1997) 2358–2367.

[6] CambienF.,PoirierO.,LecerfL.,EvansA.,CambouJ.P.,ArveilerD., Luc G., Bard J.M., Bara L., Ricard S., Tiret L., Amouyel P., Alhenc-Gelas F., SoubrierF.,Deletionpolymorphisminthegeneforangiotensin-converting enzymeisapotentriskfactorformyocardialinfarction,Nature359(1992) 641–644.

[15] Toupance B., Godelle B., Gouyon P.H., Schächter F., A model for antagonistic pleiotropic gene action for mortality and advanced age, Am. J. Hum. Genet. 62 (1998) 1525–1534.

[7] Dallongeville J., Roy M., Leboeuf N., Xhignesse M., Davignon J., Lussier-Cacan S., Apolipoprotein E polymorphism association with lipo- protein profile in endogenous hypertriglyceridemia and familial hyperc- holesterolemia, Arterioscler. Thromb. 11 (1991) 272–278.

[16] Galinsky D., Tysoe C., Brayne C.E., Easton D.F., Huppert Dening T.R., Paykel E.S., Rubinsztein D.C., Analysis of the apo E/apo angiotensin converting enzyme and methylenetetrahydrofolate 177–183.

[8] Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D., Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc. Natl. Acad. Sci. USA 90 (1993) 1977–1981.

[17] Sambrook J., Fritsch E.F., Maniatis T., Molecular Cloning: A Labo- ratory Manual, 2nd ed, Cold Spring Harbour Laboratory Press, Cold Spring Harbour, 1989.

[18] Rigat B., Hubert C., Corvol P., Soubrier F., PCR detection of the insertion/deletion polymorphism of the human Angiotensin Converting Enzyme gene, Nucl. Acids Res. 20 (1992) 1433.

[9] Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S., Apolipoprotein E polymorphism and Alzheimer’s disease, Lancet 342 (1993) 697–699.

[10] Schächter F., Faure-Delanef L., Guénot F., Rouger H., Froguel P., Lesueur-Ginot L., Cohen D., Genetic associations with human longevity at the APOE and ACE loci, Nat. Genet. 6 (1994) 29–32.

[19] Hixson J.E., Vernier D.T., Restriction isotyping of human apolipo- protein E by gene amplification and cleavage with HhaI, J. Lipid. Res. 31 (1990) 545–548.

134

[20] Terwilliger J.D., Ott J., Handbook of Human Genetic Linkage, The Johns Hopkins University Press, The Johns Hopkins Press, Baltimore, 1994.

[24] Miyata M., Smith J.D., Apolipoprotein E allele-specific antioxi- dant activity and effects on cytotoxicity by oxidative insults and beta- amyloid peptides, Nat. Genet. 14 (1996) 55–61.

[25] Payami H., Zareparsi S., Montee K.R., Sexton G.J., Kaye J.A., Bird T.D., Yu C.E., Wijsman E.M., Heston L.L., Litt M., Schellenberg G.D., Gender difference in apolipoprotein E-associated risk for familial Alzhe- imer disease: a possible clue to the higher incidence of Alzheimer disease

[21] Luc G., Bard J.M., Arveiler D., Evans A., Cambou J.P., Bingham A., Amouyel P., Schaffer P., Ruidavets J.B., Cambien F., Fruchart J.C., Duci- metiere P., Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study, Arterioscler. Thromb. 14

[26] Faure-Delanef L., Baudin B., Bénéteau-Burnat B., Beaudoin J.C., Giboudeau J., Cohen D., Plasma concentration, kinetic constants, and gene polymorphism of angiotensin I-converting enzyme in centenarians, Clin. Chem. 44 (1998) 2083–2087.

[22] Lonjou C., Clayton J., Cambon-Thomsen A., Raffoux C., HLA -A, -B, -DR haplotype frequencies in France-implications for recruitment of potential bone marrow donors, Transplantation 60 (1995) 375–383.

[27] Lindpaintner K., Pfeffer M.A., Kreutz R., Stampfer M.J., Grod- stein F., LaMotte F., Buring J., Hennekens C.H., A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease, N. Engl. J. Med. 332 (1995) 706–711.

[23] Lucotte G., Loirat F., Hazout S., Pattern of gradient of apolipopro- tein E allele *4 frequencies in western Europe, Hum. Biol. 69 (1997) 253–262.

135